2.16.840.1.113883.5.145/static-2012-07-24
| Codesystem Name | Codesystem Id | Version / Eingangsdatum | Status | |
|---|---|---|---|---|
| VaccineType | 2.16.840.1.113883.5.145 | 2012-07-24 | definitiv | |
| Level/Typ | Code | Anzeigename | Beschreibung | |
| 0-L | 54 | (en-US) adenovirus, type 4 | adenovirus vaccine, type 4, live, oral | |
| 0-L | 55 | (en-US) adenovirus, type 7 | adenovirus vaccine, type 7, live, oral | |
| 0-L | 82 | (en-US) adenovirus, NOS | adenovirus vaccine, NOS | |
| 0-L | 24 | (en-US) Anthrax | anthrax vaccine | |
| 0-L | 19 | (en-US) BCG | Bacillus Calmette-Guerin vaccine | |
| 0-L | 27 | (en-US) botulinum antitoxin | botulinum antitoxin | |
| 0-L | 26 | (en-US) Cholera | cholera vaccine | |
| 0-L | 29 | (en-US) CMVIG | cytomegalovirus immune globulin, intravenous | |
| 0-L | 56 | (en-US) dengue fever | dengue fever vaccine | |
| 0-L | 12 | (en-US) diphtheria antitoxin | diphtheria antitoxin | |
| 0-L | 28 | (en-US) DT (pediatric) | diphtheria and tetanus toxoids, adsorbed for pediatric use | |
| 0-L | 20 | (en-US) DTaP | diphtheria, tetanus toxoids and acellular pertussis vaccine | |
| 0-L | 50 | (en-US) DTaPHib | DTaP-Haemophilus influenzae type b conjugate vaccine | |
| 0-L | 1 | (en-US) DTP | diphtheria, tetanus toxoids and pertussis vaccine | |
| 0-L | 22 | (en-US) DTP-Hib | DTP-Haemophilus influenzae type b conjugate vaccine | |
| 0-L | 57 | (en-US) Hantavirus | hantavirus vaccine | |
| 0-L | 52 | (en-US) Hep A, adult | hepatitis A vaccine, adult dosage | |
| 0-L | 83 | (en-US) Hep A, ped/adol, 2 dose | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | |
| 0-L | 84 | (en-US) Hep A, ped/adol, 3 dose | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | |
| 0-L | 31 | (en-US) Hep A, pediatric, NOS | hepatitis A vaccine, pediatric dosage, NOS | |
| 0-L | 85 | (en-US) Hep A, NOS | hepatitis A vaccine, NOS | |
| 0-L | 30 | (en-US) HBIG | hepatitis B immune globulin | |
| 0-L | 8 | (en-US) Hep B, adolescent or pediatric | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | |
| 0-L | 42 | (en-US) Hep B, adolescent/high risk infant | hepatitis B vaccine, adolescent/high risk infant dosage | |
| 0-L | 43 | (en-US) Hep B, adult | hepatitis B vaccine, adult dosage | |
| 0-L | 44 | (en-US) Hep B, dialysis | hepatitis B vaccine, dialysis patient dosage | |
| 0-L | 45 | (en-US) Hep B, NOS | hepatitis B vaccine, NOS | |
| 0-L | 58 | (en-US) Hep C | hepatitis C vaccine | |
| 0-L | 59 | (en-US) Hep E | hepatitis E vaccine | |
| 0-L | 60 | (en-US) herpes simplex 2 | herpes simplex virus, type 2 vaccine | |
| 0-L | 46 | (en-US) Hib (PRP-D) | Haemophilus influenzae type b vaccine, PRP-D conjugate | |
| 0-L | 47 | (en-US) Hib (HbOC) | Haemophilus influenzae type b vaccine, HbOC conjugate | |
| 0-L | 48 | (en-US) Hib (PRP-T) | Haemophilus influenzae type b vaccine, PRP-T conjugate | |
| 0-L | 49 | (en-US) Hib (PRP-OMP) | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | |
| 0-L | 17 | (en-US) Hib, NOS | Haemophilus influenzae type b vaccine, conjugate NOS | |
| 0-L | 51 | (en-US) Hib-Hep B | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | |
| 0-L | 61 | (en-US) HIV | human immunodeficiency virus vaccine | |
| 0-L | 62 | (en-US) HPV | human papilloma virus vaccine | |
| 0-L | 86 | (en-US) IG | immune globulin, intramuscular | |
| 0-L | 87 | (en-US) IGIV | immune globulin, intravenous | |
| 0-L | 14 | (en-US) IG, NOS | immune globulin, NOS | |
| 0-L | 15 | (en-US) influenza, split (incl. purified surface antigen) | influenza virus vaccine, split virus (incl. purified surface antigen) | |
| 0-L | 16 | (en-US) influenza, whole | influenza virus vaccine, whole virus | |
| 0-L | 88 | (en-US) influenza, NOS | influenza virus vaccine, NOS | |
| 0-L | 10 | (en-US) IPV | poliovirus vaccine, inactivated | |
| 0-L | 2 | (en-US) OPV | poliovirus vaccine, live, oral | |
| 0-L | 89 | (en-US) polio, NOS | poliovirus vaccine, NOS | |
| 0-L | 39 | (en-US) Japanese encephalitis | Japanese encephalitis vaccine | |
| 0-L | 63 | (en-US) Junin virus | Junin virus vaccine | |
| 0-L | 64 | (en-US) leishmaniasis | leishmaniasis vaccine | |
| 0-L | 65 | (en-US) leprosy | leprosy vaccine | |
| 0-L | 66 | (en-US) Lyme disease | Lyme disease vaccine | |
| 0-L | 3 | (en-US) MMR | measles, mumps and rubella virus vaccine | |
| 0-L | 4 | (en-US) M/R | measles and rubella virus vaccine | |
| 0-L | 94 | (en-US) MMRV | measles, mumps, rubella, and varicella virus vaccine | |
| 0-L | 67 | (en-US) malaria | malaria vaccine | |
| 0-L | 5 | (en-US) measles | measles virus vaccine | |
| 0-L | 68 | (en-US) melanoma | melanoma vaccine | |
| 0-L | 32 | (en-US) meningococcal | meningococcal polysaccharide vaccine | |
| 0-L | 7 | (en-US) mumps | mumps virus vaccine | |
| 0-L | 69 | (en-US) parainfluenza-3 | parainfluenza-3 virus vaccine | |
| 0-L | 11 | (en-US) pertussis | pertussis vaccine | |
| 0-L | 23 | (en-US) plague | plague vaccine | |
| 0-L | 33 | (en-US) pneumococcal | pneumococcal polysaccharide vaccine | |
| 0-L | 100 | (en-US) pneumococcal conjugate | pneumococcal conjugate vaccine, polyvalent | |
| 0-L | 70 | (en-US) Q fever | Q fever vaccine | |
| 0-L | 18 | (en-US) rabies, intramuscular injection | rabies vaccine, for intramuscular injection | |
| 0-L | 40 | (en-US) rabies, intradermal injection | rabies vaccine, for intradermal injection | |
| 0-L | 90 | (en-US) rabies, NOS | rabies vaccine, NOS | |
| 0-L | 72 | (en-US) rheumatic fever | rheumatic fever vaccine | |
| 0-L | 73 | (en-US) Rift Valley fever | Rift Valley fever vaccine | |
| 0-L | 34 | (en-US) RIG | rabies immune globulin | |
| 0-L | 74 | (en-US) rotavirus | rotavirus vaccine, tetravalent, live, oral | |
| 0-L | 71 | (en-US) RSV-IGIV | respiratory syncytial virus immune globulin, intravenous | |
| 0-L | 93 | (en-US) RSV-Mab | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | |
| 0-L | 6 | (en-US) rubella | rubella virus vaccine | |
| 0-L | 38 | (en-US) rubella/mumps | rubella and mumps virus vaccine | |
| 0-L | 75 | (en-US) smallpox | smallpox vaccine | |
| 0-L | 76 | (en-US) Staphylococcus bacterio lysate | Staphylococcus bacteriophage lysate | |
| 0-L | 9 | (en-US) Td (adult) | tetanus and diphtheria toxoids, adsorbed for adult use | |
| 0-L | 35 | (en-US) tetanus toxoid | tetanus toxoid | |
| 0-L | 77 | (en-US) tick-borne encephalitis | tick-borne encephalitis vaccine | |
| 0-L | 13 | (en-US) TIG | tetanus immune globulin | |
| 0-L | 95 | (en-US) TST-OT tine test | tuberculin skin test; old tuberculin, multipuncture device | |
| 0-L | 96 | (en-US) TST-PPD intradermal | tuberculin skin test; purified protein derivative solution, intradermal | |
| 0-L | 97 | (en-US) TST-PPD tine test | tuberculin skin test; purified protein derivative, multipuncture device | |
| 0-L | 98 | (en-US) TST, NOS | tuberculin skin test; NOS | |
| 0-L | 78 | (en-US) tularemia vaccine | tularemia vaccine | |
| 0-L | 25 | (en-US) typhoid, oral | typhoid vaccine, live, oral | |
| 0-L | 41 | (en-US) typhoid, parenteral | typhoid vaccine, parenteral, other than acetone-killed, dried | |
| 0-L | 53 | (en-US) typhoid, parenteral, AKD (U.S. military) | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | |
| 0-L | 101 | (en-US) typhoid, ViCPs | Typhoid Vi capsular polysaccharide vaccine | |
| 0-L | 91 | (en-US) typhoid, NOS | typhoid vaccine, NOS | |
| 0-L | 79 | (en-US) vaccinia immune globulin | vaccinia immune globulin | |
| 0-L | 21 | (en-US) varicella | varicella virus vaccine | |
| 0-L | 81 | (en-US) VEE, inactivated | Venezuelan equine encephalitis, inactivated | |
| 0-L | 80 | (en-US) VEE, live | Venezuelan equine encephalitis, live, attenuated | |
| 0-L | 92 | (en-US) VEE, NOS | Venezuelan equine encephalitis vaccine, NOS | |
| 0-L | 36 | (en-US) VZIG | varicella zoster immune globulin | |
| 0-L | 37 | (en-US) yellow fever | yellow fever vaccine | |
